
Cyclo Therapeutics: A US-based clinical-stage biotech firm developing treatments for unmet medical needs.
Cyclo Therapeutics is a clinical-stage biotechnology company focused on developing innovative treatments for diseases with unmet medical needs. The company's mission is to create life-changing medicines for patients and families facing challenging health conditions. Based in the United States, Cyclo Therapeutics aims to address critical gaps in current treatment options through its research and development efforts.
The company's pipeline is at the core of its operations, reflecting its commitment to advancing potential therapies through clinical trials. Cyclo Therapeutics' work spans various stages of drug development, from early research to late-stage clinical studies, as it strives to bring novel therapeutic solutions to market. The firm's dedication to scientific innovation and patient care drives its efforts to make a meaningful impact in the biotechnology sector.

Applied Therapeutics

Unicycive Therapeutics
unicycive.com

Bio Green Med Solution
cyclacel.com
CyThera

Theracos
theracos.com

NeuroTherapeutics Pharma

NKT Therapeutics

Incyclix Bio
incyclixbio.com

Spheringenics

EyeCyte
eyecyte.com

Therapyx
therapyxinc.com

Underdog Pharmaceuticals
cyclaritytx.com

Celsius Therapeutics
celsiustx.com

Armetheon

Stealth BioTherapeutics
stealthbt.com
Companies similar to Cyclo Therapeutics include Applied Therapeutics, Unicycive Therapeutics, Bio Green Med Solution and CyThera.
Cyclo Therapeutics was founded in 1990.
Cyclo Therapeutics' headquarters is located in Gainesville, FL, US.
Cyclo Therapeutics' most recent funding round was for $5M (USD) in June 2023.
As of Jun 5, 2023, Cyclo Therapeutics has raised a total of $16.8M (USD).
Cyclo Therapeutics has 9 employees as of Feb 6, 2024.